isosorbide dinitrate has been researched along with cardiovascular agents in 46 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 4 (8.70) | 18.7374 |
1990's | 6 (13.04) | 18.2507 |
2000's | 22 (47.83) | 29.6817 |
2010's | 13 (28.26) | 24.3611 |
2020's | 1 (2.17) | 2.80 |
Authors | Studies |
---|---|
Adachi, H; Kodama, K; Ogawa, T; Ohhara, H | 1 |
Draganov, V; Manolov, P; Stankusheva, G | 1 |
Bochkareva, EV; Kokurina, EV; Martsevich, SIu; Shakarova, SSh; Vygodin, VA | 1 |
Fiedler, VB; Nitz, RE | 1 |
Sanchez-Cascos, A | 1 |
Follath, F | 1 |
Faggiano, P; Ghizzoni, G; Lombardi, C; Rusconi, C; Sorgato, A; Spedini, C | 1 |
Goldberg, D; Goldstein, S; Lesch, M; Levine, AB; Levine, TB; Narins, B | 1 |
Gen, H; Himura, Y; Iga, K; Inoko, M; Izumi, C; Kitaguchi, S; Kondou, H; Konishi, T; Tamura, T | 1 |
Ahn, YK; Bae, Y; Cho, JG; Cho, JH; Jeong, MH; Kang, JC; Kang, KT; Kim, KH; Kim, NH; Kim, SH; Lee, SH; Park, JC; Rhew, JY | 1 |
Hayashi, T; Ishikawa, K; Kanamasa, K; Kimura, A; Kitayama, K; Miyataka, M; Takenaka, T; Yabushita, H; Yamamoto, T | 1 |
Craven, R | 1 |
Akdeniz, B; Aslan, O; Badak, O; Goldeli, O; Guneri, S; Keskin, V; Kirimli, O; Tekin, U | 1 |
Cohn, JN; Franciosa, JA; Taylor, AL; Worcel, M | 1 |
Kugiyama, K; Yasue, H | 1 |
Kahn, J | 3 |
Kopff, A; Kopff, M; Kowalczyk, E | 1 |
Duster, T | 1 |
Saul, S | 1 |
Deng, TT; Li, XM; Luo, WJ; Wang, X; Wu, HL | 1 |
Hoffman, S | 1 |
Bibbins-Domingo, K; Fernandez, A | 2 |
Stockbridge, NL; Temple, R | 1 |
Adams, K; Carson, P; Cohn, JN; Ferdinand, K; Ofili, E; Olukotun, AY; Sabolinski, ML; Tam, SW; Taylor, AL; Taylor, M; Worcel, M; Yancy, CW; Ziesche, S | 1 |
Kahn, JD | 1 |
Fullerton, SM; Goering, S; Yu, JH | 1 |
Leslie, SJ; Megson, IL | 1 |
Abrahams, Z; Francis, GS; Mullens, W; Sokos, G; Starling, RC; Tang, WH; Taylor, DO; Young, JB | 1 |
Dries, DL; McNamara, D; Rame, JE; Sabolinski, ML; Tam, SW; Worcel, M; Wu, AH | 1 |
Chedgy, F; Howlett, DC; Inglis, C | 1 |
Clark, M; Pan, L; Payne, J | 1 |
Lim, WY; Woldman, S | 1 |
Ge, L; Gong, Y; Jiang, L; Liu, J; Liu, Q; Shi, Y; Zheng, C; Zhu, J | 1 |
Daida, H; Hiki, M; Nakazato, Y; Tokano, T | 1 |
Dixit, D; Kimborowicz, K | 1 |
Enseleit, F; Flammer, AJ; Naegele, M; Ruschitzka, F | 1 |
Marković-Peković, V; Škrbić, R | 1 |
Adhyaru, B; Raj, L | 1 |
Ağır, AA; Baydemir, C; Bozyel, S; Kandemir, AŞ; Karaüzüm, İY; Karaüzüm, K; Kozdağ, G; Ural, D | 1 |
Wu, A | 1 |
Brewster, LM | 1 |
Chakrapani, M; Kamath, A; Padakanti, A; Shenoy, A | 1 |
Al-Lamee, R; Davies, JR; Foley, M; Francis, DP; Ganesananthan, S; Gerber, R; Howard, J; Keeble, TR; Malik, IS; Nijjer, S; Nowbar, AN; O'Kane, P; Petraco, R; Rajkumar, CA; Seligman, H; Sen, S; Sharp, ASP; Shun-Shin, M; Tang, KH | 1 |
9 review(s) available for isosorbide dinitrate and cardiovascular agents
Article | Year |
---|---|
[Drug therapy in angina pectoris].
Topics: Angina Pectoris; Angina, Unstable; Calcium Channel Blockers; Cardiovascular Agents; Coronary Vasospasm; Humans; Isosorbide Dinitrate; Myocardial Infarction; Nitroglycerin; Platelet Aggregation Inhibitors; Vasodilator Agents | 1995 |
[Antianginal drugs].
Topics: Adrenergic beta-Antagonists; Angina Pectoris; Calcium Channel Blockers; Cardiovascular Agents; Humans; Isosorbide Dinitrate; Nitroglycerin; Vasodilator Agents | 1994 |
How a drug becomes "ethnic": law, commerce, and the production of racial categories in medicine.
Topics: Black or African American; Cardiovascular Agents; Commerce; Drug Approval; Drug Combinations; Drug Labeling; Heart Failure; Humans; Hydralazine; Isosorbide Dinitrate; Retrospective Studies; United States | 2004 |
LA-419, a nitric-oxide donor for the treatment of cardiovascular disorders.
Topics: Animals; Antioxidants; Cardiovascular Agents; Cardiovascular Diseases; Disease Models, Animal; Drug Tolerance; Fibrinolytic Agents; Humans; Hypertrophy, Left Ventricular; Isosorbide Dinitrate; Myocardial Ischemia; Nitric Oxide Donors; Patents as Topic; Structure-Activity Relationship; Treatment Outcome | 2009 |
Pharmacological management of chronic heart failure: old drugs, new drugs and new indications.
Topics: Adrenergic beta-Antagonists; Angiotensin Receptor Antagonists; Angiotensin-Converting Enzyme Inhibitors; Benzazepines; Cardiovascular Agents; Chronic Disease; Digoxin; Drug Combinations; Heart Failure; Heart Failure, Systolic; Humans; Hydralazine; Isosorbide Dinitrate; Ivabradine; Mineralocorticoid Receptor Antagonists | 2013 |
Pharmacologic management of chronic stable angina.
Topics: Adrenergic beta-Antagonists; Angina, Stable; Benzazepines; Calcium Channel Blockers; Cardiovascular Agents; Humans; Isosorbide Dinitrate; Ivabradine; Nicorandil; Nitroglycerin; Ranolazine; Sodium Channel Blockers; Vasodilator Agents | 2015 |
Medical therapy of heart failure with reduced ejection fraction: current evidence and new developments.
Topics: Adrenergic beta-Antagonists; Angiotensin Receptor Antagonists; Angiotensin-Converting Enzyme Inhibitors; Benzazepines; Cardiotonic Agents; Cardiovascular Agents; Digoxin; Diuretics; Heart Failure; Humans; Hydralazine; Isosorbide Dinitrate; Ivabradine; Mineralocorticoid Receptor Antagonists; Neprilysin; Stroke Volume; Vasodilator Agents | 2016 |
An evidence-based review of recent advances in therapy for heart failure with reduced ejection fraction (HFrEF).
Topics: Adrenergic beta-Antagonists; American Heart Association; Amides; Aminobutyrates; Angiotensin Receptor Antagonists; Angiotensin-Converting Enzyme Inhibitors; Anticoagulants; Antihypertensive Agents; Atrial Natriuretic Factor; Benzazepines; Biphenyl Compounds; Calcium Channel Blockers; Cardiology; Cardiotonic Agents; Cardiovascular Agents; Digoxin; Diuretics; Drug Combinations; Erythropoietin; Evidence-Based Medicine; Fumarates; Heart Failure; Hematinics; Humans; Hydralazine; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Iron; Isosorbide Dinitrate; Ivabradine; Mineralocorticoid Receptor Antagonists; Peptide Fragments; Platelet Aggregation Inhibitors; Practice Guidelines as Topic; Societies, Medical; Stroke Volume; Tetrazoles; United States; Valsartan; Vasodilator Agents | 2016 |
Heart Failure.
Topics: Adrenergic beta-Antagonists; Angiotensin Receptor Antagonists; Angiotensin-Converting Enzyme Inhibitors; Anticoagulants; Cardiac Rehabilitation; Cardiovascular Agents; Coronary Artery Disease; Defibrillators, Implantable; Diabetes Complications; Diagnostic Techniques, Cardiovascular; Digoxin; Diuretics; Heart Failure; Hospitalization; Humans; Hydralazine; Hypertension; Isosorbide Dinitrate; Ivabradine; Life Style; Mineralocorticoid Receptor Antagonists; Palliative Care; Primary Prevention; Referral and Consultation; Risk Factors | 2018 |
5 trial(s) available for isosorbide dinitrate and cardiovascular agents
Article | Year |
---|---|
Head-up tilt table testing with low dose sublingual isosorbide dinitrate in the evaluation of unexplained syncope: a comparison with isoproterenol infusion.
Topics: Administration, Sublingual; Adult; Cardiovascular Agents; Female; Humans; Infusions, Intravenous; Isoproterenol; Isosorbide Dinitrate; Male; Middle Aged; Sensitivity and Specificity; Syncope; Syncope, Vasovagal; Tilt-Table Test | 2002 |
The African-American Heart Failure Trial: background, rationale and significance.
Topics: Black or African American; Cardiovascular Agents; Drug Combinations; Heart Failure; Humans; Hydralazine; Isosorbide Dinitrate; Research Design | 2002 |
[Trial study on DENG Tie-tao's coronary heart disease capsules in improving patients' quality of life].
Topics: Aged; Angina Pectoris; Capsules; Cardiovascular Agents; Coronary Disease; Drugs, Chinese Herbal; Female; Humans; Isosorbide Dinitrate; Male; Medicine, Chinese Traditional; Middle Aged; Phytotherapy; Plant Preparations; Quality of Life; Salvia miltiorrhiza; Single-Blind Method; Treatment Outcome | 2005 |
Early and sustained benefit on event-free survival and heart failure hospitalization from fixed-dose combination of isosorbide dinitrate/hydralazine: consistency across subgroups in the African-American Heart Failure Trial.
Topics: Adult; Aged; Arthralgia; Biomarkers; Black or African American; Cardiovascular Agents; Cause of Death; Disease-Free Survival; Dizziness; Double-Blind Method; Drug Combinations; Heart Failure; Heart Transplantation; Hospitalization; Humans; Hydralazine; Hypotension; Isosorbide Dinitrate; Kaplan-Meier Estimate; Middle Aged; Mortality; Natriuretic Peptide, Brain; Nitric Oxide Donors; Proportional Hazards Models; Quality of Life; Surveys and Questionnaires; Treatment Outcome; Vasodilator Agents | 2007 |
Achieving Optimal Medical Therapy: Insights From the ORBITA Trial.
Topics: Amlodipine; Bisoprolol; Cardiovascular Agents; Coronary Angiography; Coronary Artery Disease; Dose-Response Relationship, Drug; Drug Therapy, Combination; Female; Follow-Up Studies; Fractional Flow Reserve, Myocardial; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Isosorbide Dinitrate; Male; Middle Aged; Nicorandil; Percutaneous Coronary Intervention; Ranolazine; Treatment Outcome; Vasodilator Agents | 2021 |
32 other study(ies) available for isosorbide dinitrate and cardiovascular agents
Article | Year |
---|---|
Inhibitory effect of a novel antianginal agent, E4080, on ST segment elevation induced by vasopressin in anesthetized guinea pigs.
Topics: Anesthesia; Animals; Benzopyrans; Cardiovascular Agents; Catechols; Clonidine; Coronary Vessels; Cromakalim; Electrocardiography; Guinea Pigs; Heart Rate; Imidazoles; In Vitro Techniques; Isosorbide Dinitrate; Male; Nifedipine; Pyrroles; Vasodilator Agents; Vasopressins | 1992 |
[Hemodynamic changes during treatment with isodinit, sectral, stenopril and kratemon].
Topics: Acebutolol; Adult; Aged; Cardiovascular Agents; Coronary Disease; Delayed-Action Preparations; Drug Evaluation; Female; Flavonoids; Hemodynamics; Humans; Hypertension; Isosorbide Dinitrate; Male; Middle Aged; Phenethylamines; Tablets; Time Factors | 1987 |
[Methodological approaches to assessing the effectiveness of anti-angina preparations in stenocardia patients using paired bicycle ergometry loads].
Topics: Angina Pectoris; Cardiovascular Agents; Drug Evaluation; Exercise Test; Hemodynamics; Humans; Isosorbide Dinitrate; Male; Middle Aged; Nifedipine; Physical Endurance; Propranolol | 1985 |
Effects of molsidomine, nitroglycerin, and isosorbide dinitrate on the coronary circulation, myocardial oxygen consumption, and haemodynamics in anaesthetized dogs.
Topics: Animals; Cardiovascular Agents; Coronary Circulation; Dogs; Female; Heart; Hemodynamics; Isosorbide Dinitrate; Male; Molsidomine; Morpholines; Myocardium; Nitroglycerin; Oxadiazoles; Oxygen Consumption; Sydnones | 1981 |
Evaluation of effect of drugs on the exercise ECG.
Topics: Atenolol; Blood Pressure; Cardiovascular Agents; Coronary Disease; Electrocardiography; Exercise Test; Female; Heart Rate; Humans; Isosorbide Dinitrate; Male; Middle Aged; Nifedipine; Propranolol; Verapamil | 1981 |
Pulmonary function tests in patients with congestive heart failure: effects of medical therapy.
Topics: Adult; Aged; Captopril; Cardiovascular Agents; Digoxin; Dobutamine; Drug Therapy, Combination; Echocardiography, Doppler; Forced Expiratory Volume; Furosemide; Heart Failure; Hemodynamics; Humans; Isosorbide Dinitrate; Male; Middle Aged; Nitroglycerin; Nitroprusside; Vasodilator Agents; Vital Capacity | 1993 |
Reversal of end-stage heart failure is predicted by long-term therapeutic response rather than initial hemodynamic and neurohormonal profile.
Topics: Adult; Cardiovascular Agents; Dobutamine; Dose-Response Relationship, Drug; Enalapril; Female; Follow-Up Studies; Furosemide; Heart Failure; Heart Transplantation; Hemodynamics; Humans; Isosorbide Dinitrate; Male; Middle Aged; Norepinephrine; Survival Rate; Treatment Outcome; Waiting Lists | 1996 |
Two cases of hypertrophic cardiomyopathy with coronary vasospasm.
Topics: Adrenergic beta-Antagonists; Aged; Angina Pectoris, Variant; Calcium Channel Blockers; Cardiomyopathy, Hypertrophic; Cardiovascular Agents; Coronary Vasospasm; Diltiazem; Drug Therapy, Combination; Electrocardiography; Humans; Isosorbide Dinitrate; Male; Middle Aged | 1998 |
Successful management of intractable coronary spasm with a coronary stent.
Topics: Adult; Amlodipine; Aspirin; Calcium Channel Blockers; Cardiovascular Agents; Coronary Angiography; Coronary Artery Disease; Coronary Vasospasm; Diltiazem; Doxazosin; Drug Resistance; Drug Therapy, Combination; Ergonovine; Humans; Isosorbide Dinitrate; Male; Myocardial Infarction; Nicorandil; Nitrates; Pyridines; Stents; Ticlopidine; Ventricular Fibrillation | 2000 |
Intermittent nitrate therapy for prior myocardial infaraction does not induce rebound angina nor reduce cardiac events.
Topics: Administration, Cutaneous; Administration, Oral; Aged; Angina Pectoris; Cardiovascular Agents; Coronary Vasospasm; Delayed-Action Preparations; Disease-Free Survival; Drug Administration Schedule; Drug Therapy, Combination; Drug Tolerance; Exercise Tolerance; Female; Follow-Up Studies; Heart Failure; Humans; Isosorbide Dinitrate; Male; Middle Aged; Myocardial Infarction; Nitroglycerin; Recurrence; Retrospective Studies; Treatment Outcome | 2000 |
Tailored treatments.
Topics: Black or African American; Cardiovascular Agents; Drug Combinations; Heart Failure; Humans; Hydralazine; Isosorbide Dinitrate | 2001 |
[Inhibition of adenosine deaminase activity by drugs influencing the cardiovascular system].
Topics: Adenosine; Adenosine Deaminase Inhibitors; Animals; Aspirin; Cardiovascular Agents; Cardiovascular System; Deoxyadenosines; Female; Fibrinolytic Agents; Isoenzymes; Isosorbide Dinitrate; Male; Metoprolol; Molsidomine; Rabbits; Random Allocation; Simvastatin; Vasodilator Agents; Vasomotor System | 2004 |
Medicine. Race and reification in science.
Topics: Bias; Cardiovascular Agents; Crime; Databases, Nucleic Acid; Drug Combinations; Forensic Sciences; Gene Frequency; Genetic Variation; Genetics, Medical; Heart Diseases; Humans; Hydralazine; Hypertension; Isosorbide Dinitrate; Pharmacogenetics; Phenotype; Polymorphism, Single Nucleotide; Racial Groups | 2005 |
U.S. to review drug intended for one race.
Topics: Black or African American; Cardiovascular Agents; Clinical Trials as Topic; Drug Approval; Drug Combinations; Drug Industry; Heart Failure; Humans; Hydralazine; Isosorbide Dinitrate; Marketing of Health Services; Pharmacogenetics; Racial Groups; United States; United States Food and Drug Administration | 2005 |
Misreading race and genomics after BiDil.
Topics: Black or African American; Cardiovascular Agents; Drug Approval; Drug Combinations; Genomics; Heart Failure; Humans; Hydralazine; Isosorbide Dinitrate; United States; United States Food and Drug Administration | 2005 |
"Racially-tailored" medicine unraveled.
Topics: Cardiovascular Agents; Civil Rights; Delivery of Health Care; Drug Combinations; Ethics Committees, Research; Federal Government; Financing, Government; Genetic Research; Heart Failure; Humans; Hydralazine; Isosorbide Dinitrate; National Institutes of Health (U.S.); Organizational Policy; Patient Rights; Pharmacogenetics; Prejudice; Racial Groups; State Government; United States | 2005 |
BiDil for heart failure in black patients: implications of the U.S. Food and Drug Administration approval.
Topics: Black People; Cardiovascular Agents; Drug Approval; Drug Combinations; Heart Failure; Humans; Hydralazine; Isosorbide Dinitrate; Public Policy; Randomized Controlled Trials as Topic; United States; United States Food and Drug Administration | 2007 |
BiDil for heart failure in black patients: The U.S. Food and Drug Administration perspective.
Topics: Black People; Cardiovascular Agents; Drug Approval; Drug Combinations; Heart Failure; Humans; Hydralazine; Isosorbide Dinitrate; Public Policy; Randomized Controlled Trials as Topic; United States; United States Food and Drug Administration | 2007 |
BiDil for heart failure in black patients.
Topics: Black People; Cardiovascular Agents; Drug Approval; Drug Combinations; Heart Failure; Humans; Hydralazine; Isosorbide Dinitrate; United States; United States Food and Drug Administration | 2007 |
BiDil for heart failure in black patients.
Topics: Black People; Cardiovascular Agents; Drug Approval; Drug Combinations; Heart Failure; Humans; Hydralazine; Isosorbide Dinitrate; United States; United States Food and Drug Administration | 2007 |
Race-based medicine and justice as recognition: exploring the phenomenon of BiDil.
Topics: Black or African American; Cardiovascular Agents; Drug Approval; Drug Combinations; Drug Design; Ethical Theory; Healthcare Disparities; Heart Failure; History, 20th Century; History, 21st Century; Humans; Hydralazine; Isosorbide Dinitrate; Social Justice; United States | 2009 |
Exploiting race in drug development: BiDil's interim model of pharmacogenomics.
Topics: Cardiovascular Agents; Drug Combinations; History, 20th Century; History, 21st Century; Humans; Hydralazine; Intellectual Property; Isosorbide Dinitrate; Pharmacogenetics; Racial Groups; United States; United States Food and Drug Administration | 2008 |
Usefulness of Isosorbide Dinitrate and Hydralazine as add-on therapy in patients discharged for advanced decompensated heart failure.
Topics: Adult; Aged; Angiotensin II Type 1 Receptor Blockers; Angiotensin-Converting Enzyme Inhibitors; Cardiovascular Agents; Female; Heart Failure; Humans; Hydralazine; Isosorbide Dinitrate; Male; Middle Aged | 2009 |
Dysfunctional corin i555(p568) allele is associated with impaired brain natriuretic peptide processing and adverse outcomes in blacks with systolic heart failure: results from the Genetic Risk Assessment in Heart Failure substudy.
Topics: Black or African American; Cardiovascular Agents; Double-Blind Method; Drug Combinations; Female; Gene Frequency; Genetic Predisposition to Disease; Heart Failure, Systolic; Hospitalization; Humans; Hydralazine; Immunoassay; Isosorbide Dinitrate; Kaplan-Meier Estimate; Male; Middle Aged; Multicenter Studies as Topic; Mutation; Natriuretic Peptide, Brain; Phenotype; Proportional Hazards Models; Protein Processing, Post-Translational; Randomized Controlled Trials as Topic; Retrospective Studies; Risk Assessment; Risk Factors; Serine Endopeptidases; Treatment Outcome; United States | 2009 |
A case of recurrent ventricular tachycardia.
Topics: Aged; Atorvastatin; Cardiovascular Agents; Digoxin; Drug Therapy, Combination; Female; Furosemide; Heptanoic Acids; Humans; Isosorbide Dinitrate; Lisinopril; Nitroglycerin; Pyrroles; Recurrence; Tachycardia, Ventricular; Warfarin | 2011 |
Question: does isosorbide dinitrate/hydralazine therapy benefit systolic heart failure patients with renal insufficiency?
Topics: Angiotensin-Converting Enzyme Inhibitors; Cardiovascular Agents; Drug Combinations; Evidence-Based Medicine; Heart Failure, Systolic; Hemodynamics; Humans; Hydralazine; Isosorbide Dinitrate; Randomized Controlled Trials as Topic; Renal Insufficiency; Treatment Outcome | 2011 |
A novel multi-unit tablet for treating circadian rhythm diseases.
Topics: Administration, Oral; Angina Pectoris; Cardiovascular Agents; Cellulose; Chemistry, Pharmaceutical; Chronobiology Disorders; Delayed-Action Preparations; Drug Carriers; Excipients; Hypromellose Derivatives; Isosorbide Dinitrate; Kinetics; Methacrylates; Methylcellulose; Microscopy, Electron, Scanning; Polymers; Solubility; Tablets; Technology, Pharmaceutical | 2013 |
Recurrent ventricular fibrillation under sufficient medical treatment in patient with coronary artery spasm.
Topics: Cardiovascular Agents; Coronary Vasospasm; Defibrillators, Implantable; Diagnosis, Differential; Diltiazem; Echocardiography; Electrocardiography; Female; Humans; Isosorbide Dinitrate; Middle Aged; Nicorandil; Recurrence; Treatment Outcome; Ventricular Fibrillation | 2013 |
Long-term drug use and polypharmacy among the elderly population in the Republic of Srpska, Bosnia and Herzegovina.
Topics: Age Factors; Aged; Aged, 80 and over; Aminophylline; Angiotensin-Converting Enzyme Inhibitors; Anti-Arrhythmia Agents; Antihypertensive Agents; Bosnia and Herzegovina; Bronchodilator Agents; Calcium Channel Blockers; Cardiovascular Agents; Digoxin; Female; Humans; Hypoglycemic Agents; Isosorbide Dinitrate; Male; Polypharmacy; Retrospective Studies; Sex Factors; Vasodilator Agents | 2016 |
Effect of Oral Nitrates on All-Cause Mortality and Hospitalization in Heart Failure Patients with Reduced Ejection Fraction: A Propensity-Matched Analysis.
Topics: Aged; Cardiovascular Agents; Female; Heart Failure; Hospitalization; Humans; Isosorbide Dinitrate; Male; Middle Aged; Mortality; Propensity Score; Retrospective Studies; Risk Factors; Stroke Volume; Survival Analysis; Turkey; Ventricular Dysfunction, Left | 2017 |
Underuse of hydralazine and isosorbide dinitrate for heart failure in patients of African ancestry: a cross-European survey.
Topics: Black People; Cardiovascular Agents; Cross-Sectional Studies; Databases, Pharmaceutical; Drug Combinations; Drug Prescriptions; Europe; Heart Failure; Humans; Hydralazine; Isosorbide Dinitrate | 2019 |
Drug-induced Hemolysis in G6PD Deficiency: an Unusual Presentation of a Common Clinical Condition.
Topics: Cardiovascular Agents; Drug Combinations; Glucosephosphate Dehydrogenase Deficiency; Hemolysis; Humans; Hydralazine; Isosorbide Dinitrate; Male; Middle Aged | 2019 |